Friday, 29 March 2024
Proteostasis Therapeutics Inc.
NASDAQ : PTI
1.110 22 Dec 20 00:00 | Change: 0.04 | Open: 1.170 | High: 1.200 | Ask: 0.000 | Volume: 2,110,100 |
Change(%): 3.48 | Prev: 1.150 | Low: 1.100 | Bid: 0.000 | Avg vol: 0 |
05:18 | 16/3/18
Post Analyst
Atomera Incorporated (NASDAQ:ATOM) recorded a trading volume of 1.07 million shares, above its 90-day volume average of 0.09 million shares.
more»
23:30 | 15/3/18
Wall Street Morning
On Wednesday, Proteostasis Therapeutics, Inc. (PTI) made the way into the market positive movers list with rising 2.74%.
more»
09:26 | 15/3/18
GlobeNewswire
CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other ...
more»
00:15 | 15/3/18
Market Exclusive
On March14, 2018, Proteostasis Therapeutics, Inc. (the “Company”) expects to disclose the following information in discussions to be held in connection with the Cowen& Co.
more»
11:07 | 14/3/18
Danvers Record
The Price to Book ratio for Proteostasis Therapeutics, Inc. NasdaqGM:PTI is 3.560229. The Price to book ratio is the current share price of a company divided by the book value per share.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |